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Health careAbstract In this study, it was aimed to investigate the utilization of antibiotics at various health
care facilities. Photocopies of 1250 prescriptions which were containing antibiotics and written
out in primary health care facilities (PHCFs), public hospitals (PHs), private hospitals and univer-
sity hospitals in 10 provinces across Turkey, were evaluated by some drug use indicators. The num-
ber of drugs per prescription was 3.23 ± 0.92 and it was highest in PHCFs (3.34 ± 0.84),
(p< 0.05). The cost per prescription was 33.3 $, being highest in PHs while being lowest in PHCFs
(38.6 $ and 28.2 $ respectively). Antibiotic cost per prescription was 16.7 $ and it was also highest
and lowest in PHs and PHCFs respectively (p< 0.05). The most commonly prescribed group of
antibiotics was ‘‘beta-lactam antibacterials, penicillins’’ (29.2%) while amoxicillin/clavulanic acid
was the most commonly prescribed antibiotic (18.1%). Sixty-one percent of the antibiotics pre-
scribed for acute infections was generics; among facilities being highest in PHCFs (66.5%) and
among diagnosis being highest in acute pharyngitis. In general, the duration of antibiotic therapy
was approximately 7 days for acute infections. Although much more drugs were prescribed in
PHCFs than others, it was found to be in an inverse proportion with both the total cost of prescrip-
tions and the cost of antibiotics. Broad-spectrum antibiotics, beta-lactamase combinations in par-
ticular, were considered to be more preferable in all health care facilities is also notable. These
results do serve as a guide to achieve the rational use of antibiotics on the basis of health care facil-
ities and indications.
ª 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Antibiotics are the agents which are commonly used in the
treatment of bacterial infections. In spite of their advantages
in treatment, the problems that occur from the irrational use
of antibiotics (IUA) have put them in the health agendas of
the countries as a common issue of consideration (Holloway
and van Dijk, 2011; WHO, 2001; European Parliament
282 S. Mollahaliloglu et al.Directorate General for Internal Policies of the Union, 2006;
Gould and van der Meer, 2005). The use of antibiotics for viral
infections, unnecessarily prescribing broad-spectrums, use of
inappropriate doses and durations, patients’ self-treatments,
etc. can be given as the examples of IUA which lead to antibi-
otic resistance, ineffective treatment and increased health
expenditures (WHO, 2001; European Parliament Directorate
General for Internal Policies of the Union, 2006; Ochoa
et al., 2000; Llor et al., 2009; Colgan and Powers, 2001).
Countries have taken some initiatives at national and inter-
national levels in order to promote the rational use of antibiot-
ics (WHO, 2001; Gould and van der Meer, 2005; Shah and
Shah, 2008; Mo¨lstad and Cars, 1999; Goossens et al., 2006).
In spite of these initiatives, IUA still remains as a problem
which can be caused by physicians or many other factors such
as patients, physical working environments of medical prac-
tice, etc. (Colgan and Powers, 2001; Kotwani et al., 2010;
Niederman, 2005; Ozgenc¸ et al., 2011). Physicians are the
health professionals who are primarily responsible for treat-
ment and to know about their prescribing practices can con-
tribute to the achievement of initiatives and regulations
relevant to IUA (WHO, 2002, 2003; Natsch, 2005). With the
‘‘Health Transformation Program’’ launched in 2003, the
Turkish Ministry of Health (MoH) identiﬁed a number of
strategies aiming to prevent the irrational use of drugs in
Turkey. Conducting ﬁeld surveys and providing scientiﬁc evi-
dences are among these strategies (Akdag˘, 2011). Most of
the studies examining the prescribing attitudes of physicians
in the literature are usually, speciﬁc to a particular health care
facility, a region, an indication or an age group (Aydın et al.,
2005; Lundborg et al., 2002; Pathak et al., 2011; Akici et al.,
2004; Rossignoli et al., 2007; Ceyhan et al., 2010; Bjerrum
et al., 2004; Baktygul et al., 2011; Pela´ez-Ballestas et al.,
2003; Avci et al., 2006; Sharma et al., 2009; Kumar et al.,
2010; Vojvodic´, 2010; Vaccheri et al., 2002). Nonetheless, it
is needed to carry out comprehensive researches that make
an assessment of the use of antibiotics by various health care
facilities. In this study, it was aimed to analyze the contents
of the antibiotic prescribed scripts which were written out in
various health care facilities in various provinces across
Turkey.
2. Material and methods
A comprehensive study assessing the prescriptions from vari-
ous health care facilities was carried out in 2009 under the
responsibility of the School of Public Health (TUSAK), with
the permission given by Turkish MoH. In this manuscript,
only antibiotic containing prescriptions which were collected
within the scope of this study were analyzed. Photocopies of
the prescriptions, which were written out in the primary health
care facilities (PHCFs), public hospitals (PHs), private hospi-
tals (PTE-Hs) and university hospitals (UHs) in November–
December 2009, were collected by randomization during the
patients’ visits to the pharmacies. Of these prescriptions, a to-
tal of 1250 prescriptions containing antibiotics were analyzed
retrospectively in this study.
Turkey has 81 provinces and the population was 72.561.312
as of 2009 (Turkish Statistical Institute, 2011). In this cross-
sectional study, the prescriptions containing antibiotics, which
were written out in PHCFs, PHs, PTE-Hs and UHs running in10 provinces (Eskisehir, Denizli, Nigde, Nevsehir, Bartin,
Karabuk, Gumushane, Bayburt, Cankiri and Kirsehir) that
are located in various geographical regions of Turkey, were as-
sessed in detail by drug utilization indicators. Data were col-
lected by a member of the survey team and a health care
professional who was practicing in that province. The prescrip-
tions written out in PHCFs and PHs were collected in all of 10
provinces where the survey was conducted. The prescriptions
written out in UHs were collected in Denizli and Eskisehir
provinces since they have medical schools; except Gumushane
and Bayburt provinces, since no private hospitals were avail-
able, the prescriptions written out in PTE-Hs were collected
in all provinces. The provinces were selected randomly and
in order to avoid from any bias, utmost signiﬁcance was at-
tached to selecting provinces where no pilot study was con-
ducted before for the purpose of rational use of drugs (RUD).
The prescriptions were computerized into the databases
that were speciﬁcally developed with the Excel and SPSS. They
were assessed for number of drugs per prescription (NDPP),
number of antibiotics per prescription (NAPP), cost per pre-
scription (CPP), antibiotic cost per prescription (ACPP), main
groups of all drugs written on the prescriptions, groups of anti-
biotics, the most frequently prescribed antibiotics, etc.
Some of the prescriptions included more than one diagno-
sis. Among the prescriptions, the ones with a diagnosis of a
single infection (n= 951) were analyzed in detail in another
study (Mollahalilog˘lu et al., 2012). In the present study, among
single-diagnosis prescriptions which were indicated ‘‘acute’’
(n= 343) were assessed in terms of the ‘‘average duration of
antibiotic therapy’’ and ‘‘generic or original antibiotic pre-
scribing’’. These assessments were also speciﬁcally reviewed
for the most common ﬁrst four indications. The antibiotic
groups and generic antibiotics, which were preferred for these
top four indications, were speciﬁcally examined for ‘‘acute
indications’’. The information regarding the duration of anti-
biotic therapy was not available in the prescriptions. There-
fore, the duration of antibiotic therapy was determined by
prescribed total amount and instructions of antibiotics for
acute indications. While considering the average duration of
antibiotic therapy, the prescriptions, which did not indicate
doses, and the pharmaceutical forms, which can be used exter-
nally, were not included in order to obtain quantitative data.
ANOVA, Tukey Hsd, Kruskal Wallis and Chi-Square tests
were used in the statistical analyses. The comparisons were
considered as statistically signiﬁcant, if p< 0.05. Drugs were
grouped by the ATC (Anatomic Therapeutic Chemical) classi-
ﬁcation. While calculating the prices of drugs, the values estab-
lished by MoH at the date of data collection were taken into
consideration. In this study, these prices were given in the
US Dollars ($) by the foreign exchange rate that was effective
on the date of the survey.
3. Results
In this study, 1250 prescriptions, which were written out by
535 physicians practicing in various health care facilities
(including PHCFs, PHs, PTE-Hs and UHs) in 10 provinces
were analyzed (prescription per physician n= 2.3). Of the
1250 prescriptions, 423 (33.8%) were written out in PHCFs,
382 in PTE-Hs (30.6%), 371 in PHs (29.7%) and 74 (5.9%)
in UHs. The mean age of the patients was 35.68 ± 23.41
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prescriptions were written out by male physicians (70.5%).
The prescriptions containing antibiotics were written
mostly by general practitioners (GPs), (33.8%), followed by
specialists in pediatrics (12.2%), otolaryngology (11.5%), chest
diseases (7.4%) and internal medicine (7.0%), (Fig. 1). In gen-
eral, 33.8% of the prescriptions were written out by GPs,
34.9% by surgical medicine specialists and 31.3% by internal
medicine specialists.
Some of the prescriptions included more than one diagno-
ses (number of diagnosis per prescription = 1.7). A total of
2057 diagnoses were written and pharyngitis (12.5%) was the
most common followed by bronchitis (8.4%), sinusitis
(7.9%) and tonsillitis (7.5%). The rank was also found to be
the same in the distribution of the ‘‘acute’’ infectious diagnosis
(Table 1).
Nearly half of the prescriptions (49.1%; n= 614) included
analgesics, 10.6% (n= 132) of any injectable drugs and 7.8%
(n= 98) of injectable antibiotics. Within the injectable drug
prescribed scripts, three-fourth of them (74.2%) included
injectable antibiotics.
A total of 4038 medicines were prescribed. NDPP was
3.23 ± 0.92 and it was highest in PHCFs (3.34 ± 0.84) and
lowest in PHs (3.12 ± 1.00). NDPP by health care facilities
showed statistically signiﬁcant differences which were related
to the higher NDPP in PHCFs than PHs (p< 0.05). Of the
4038 medicines, 34.8% (n= 1403) was antibiotics. NAPP
was 1.12 ± 0.35, being highest in PTE-Hs (1.21 ± 0.44) and
lowest in PHCFs (1.04 ± 0.19). NAPP by health care facilities
showed statistically signiﬁcant differences (p< 0.05). These
differences were between PHCFs and all other facilities, and
between PHs and PTE-Hs (Table 2). Of 1403 antibiotics,
7.3% (n= 103) was injectable.
The total cost of all prescribed medicines was 41655,36 $.
The CPP was 33.32 ± 33.50 $, being highest in PHs
(38.62 ± 46.57 $) and lowest in PHCFs (28.23 ± 19.62 $).
CPP by health care facilities showed statistically signiﬁcant dif-
ferences. The CPP was higher in PHs than PHCFs (p< 0.05).
The ACPP was 16.73 ± 13.62 $, being highest in PHs andFigure 1 Distribution of the prescrPTE-Hs (17.87 ± 15.68 $ and 17.71 ± 14.31 $, respectively)
and lowest in PHCFs (15.08 ± 11.42 $). ACPP by health care
facilities showed statistically signiﬁcant differences. The ACPP
was lower in PHCFs than PHs and PTE-Hs (p< 0.05), (Ta-
ble 2). The cost of antibiotics was 20917,68 $, which consti-
tuted 50.2% of the total cost of all the drugs prescribed. The
cost of injectable antibiotics was 2577,19 $, which constituted
12.3% of the total antibiotic cost.
‘‘Systemic anti-infectives’’ (ATC code: J; 31.3%) was the
most commonly prescribed drug group on prescriptions, fol-
lowed by ‘‘respiratory system medicines’’ (R; 26.6%) and
‘‘musculo-skeletal system medicines’’ (M; 10.6%). Except
PHCFs, ‘‘systemic anti-infectives’’ were found to be the most
frequently prescribed drug group in the health care facilities
and in PHCFs, it was ‘‘respiratory system medicines (R)’’,
(Table 3).
When the ATC group distributions of all antibiotics were
analyzed, ‘‘beta-lactam antibacterials, penicillins’’ (ATC code:
J01C; 29.2%) were the most frequently prescribed antibiotics
followed by ‘‘other beta-lactam antibacterials’’ (J01D;
28.0%), ‘‘quinolone antibacterials (J01M; 15.8%)’’ and ‘‘mac-
rolides, lincosamides and streptogramins’’ (J01F; 8.9%)’’. In
PHCFs and UHs, ‘‘beta-lactam antibacterials, penicillins’’
(39.5% and 34.1%, respectively)’’ were the most frequently
prescribed antibiotics while in PHs and PTE-Hs, it was ‘‘other
beta-lactam antibacterials’’ (26.9% and 27.8%, respectively)’’,
(Table 4).
Amoxicillin + clavulanic acid (18.1%) was the most pre-
scribed antibiotic followed by cefuroxime (9.5%), ciproﬂoxa-
cin (4.7%), moxiﬂoxacin (4.7%) and levoﬂoxacin (4.6%).
Amoxicillin + clavulanic acid was found also to be the most
prescribed antibiotic in all health care facilities. The second
most frequently prescribed antibiotic had a similar trend and
was found to be cefuroxime in all health care facilities
(Table 5).
Of the total 1250 prescriptions, 951 had one diagnosis
(76.1%). Among these one-diagnosed prescriptions, those indi-
cated as acute (A.), (n= 343) were subjected to additional
analyses (Table 1). The groups of antibiotics prescribed foriptions by physicians’ specialties.
Table 2 Distribution of the average number of drugs per prescription (NDPP), average cost per prescription (CPP), average number
of antibiotics per prescription (NAPP) and average antibiotic cost per prescription (ACPP) by healthcare facilities.
Healthcare
facilities
(n=Total
number of prescriptions)
NDPP± SD
(n=Total
number of drugs)
CPP ± SD ($) NAPP ± SD
(n= Total number
of antibiotics)
ACPP ± SD ($)
PHCF (n= 423) 3.34 ± 0.84 (n= 1411) 28.23 ± 19.62 1.04 ± 0.19 (n= 438) 15.08 ± 11.42
PH (n= 371) 3.12 ± 1.00 (n= 1157) 38.62 ± 46.57 1.12 ± 0.35 (n= 416) 17.87 ± 15.68
PTE-H (n= 382) 3.22 ± 0.94 (n= 1230) 33.89 ± 30.38 1.21 ± 0.44 (n= 461) 17.71 ± 14.31
UH (n= 74) 3.24 ± 0.89 (n= 240) 32.95 ± 29.49 1.19 ± 0.43 (n= 88) 15.46 ± 8.63
Total (n= 1250) 3.23 ± 0.92 (n= 4038) 33.32 ± 33.50 1.12 ± 0.35 (n= 1403) 16.73 ± 13.62
Statistics F= 3.682 F= 6.465 F= 17.535 F= 3.854
p= 0.012 p= 0.000 p= 0.000 p= 0.009
Table 3 Distribution of the ATC classiﬁcation of all the prescribed medicines by healthcare facilities.
ATC classiﬁcation PHCF PH PTE-H UH Total
n % n % n % n % n %
Alimentary tract and metabolism (A) 154 10.9 94 8.1 114 9.3 25 10.4 387 9.6
Blood and blood forming organs (B) 8 0.6 15 1.3 14 1.1 4 1.7 41 1.0
Cardiovascular system (C) 32 2.3 9 0.8 12 1.0 4 1.7 57 1.4
Dermatologicals (D) 42 3.0 40 3.5 30 2.4 10 4.2 122 3.0
Genito urinary system and sex hormones (G) 5 0.4 21 1.8 22 1.8 3 1.3 51 1.3
Systemic hormonal prep. excluding sex hormones (H) 2 0.1 5 0.4 8 0.7 – – 15 0.4
General antiinfectives for systemic use (J) 419 29.7 367 31.7 398 32.4 79 32.9 1263 31.3
Antineoplastic and immunomodulating agents (L) – – 1 0.1 2 0.2 – – 3 0.1
Musculo-skeletal system (M) 171 12.1 106 9.2 123 10.0 27 11.3 427 10.6
Nervous system (N) 114 8.1 85 7.3 89 7.2 21 8.8 309 7.7
Antiparasitic products (P) 7 0.5 11 1.0 9 0.7 6 2.5 33 0.8
Respiratory system (R) 444 31.5 316 27.3 271 22.0 45 18.8 1076 26.6
Sensory organs (S) 11 0.8 85 7.3 137 11.1 16 6.7 249 6.2
Various (V) 2 0.1 2 0.2 1 0.1 – – 5 0.1
Table 1 Distribution of the most commonly written diagnoses on prescriptions (*, percentage by 1250 prescriptions).
Diagnoses Diagnoses on prescriptions Diagnoses on prescriptions which were stated as ‘‘acute’’ infections
n % %* n % %*
Pharyngitis 258 12.5 20.6 106 30.9 8.5
Bronchitis 173 8.4 13.8 90 26.2 7.2
Sinusitis 163 7.9 13.0 57 16.6 4.6
Tonsillitis 155 7.5 12.4 58 16.9 4.7
Others 1308 63.6 104.6 32 9.3 2.6
Total 2057 100.0 – 343 100.0 27.4
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ingly, for A. pharyngitis, ‘‘beta-lactam antibacterials, penicil-
lins’’ (J01C; 46.3%)’’ and ‘‘other beta-lactam antibacterials’’
(J01D; 34.3%); for A. bronchitis, ‘‘other beta-lactam antibac-
terials (J01D; 33.7%) and ‘‘quinolone antibacterials’’ (J01M;
27.4%); for A. sinusitis, ‘‘other beta-lactam antibacterials’’
(J01D; 36.2%) and ‘‘beta-lactam antibacterials, penicillins’’
(J01C; 34.5%); for A. tonsillitis, ‘‘beta-lactam antibacterials,
penicillins’’ (J01C; 66.7%) and ‘‘other beta-lactam antibacteri-
als (J01D; 26.7%) were the most frequently prescribed groups
of antibiotics (Table 6).
The most frequently prescribed antibiotics were analyzed
for the most common A. infectious diseases. Accordingly, forA. pharyngitis amoxicillin + clavulanic acid (29.6%), cefurox-
ime (9.3%) and cefaclor (6.5%); for A. bronchitis cefuroxime
(15.8%), amoxicillin + clavulanic acid (11.6%) and clarithro-
mycin (10.5%); for A. sinusitis amoxicillin + clavulanic acid
(27.6%) and with the same percentage (6.9%) cefuroxime, cef-
aclor and ceﬁxime; for A. tonsillitis amoxicillin + clavulanic
acid (46.7%), cefuroxime (10.0%) and combinations (6.7%)
were the most frequently prescribed antibiotics (Table 7).
For A. infections, giving a consideration to the quantity of
drugs prescribed and the recommended daily doses, the
durations of antibiotic therapy were also examined.
Accordingly, the average duration of antibiotic therapy was
6.83 ± 2.52 days (min: 1, max: 20 days) for A. infections.
Table 4 Distribution of the ATC 4 classiﬁcation of antibiotics by healthcare facilities.
ATC classiﬁcation PHCF PH PTE-H UH Total
n % n % n % n % n %
Beta-lactam antibacterials, penicillins (J01C) 173 39.5 100 24.0 107 23.2 30 34.1 410 29.2
Other beta-lactam antibacterials (J01D) 137 31.3 112 26.9 128 27.8 16 18.2 393 28.0
Quinolone antibacterials (J01M) 33 7.5 82 19.7 88 19.1 19 21.6 222 15.8
Macrolides, lincosamides and streptogramins (J01F) 55 12.6 32 7.7 32 6.9 6 6.8 125 8.9
Anti-infectives (S01A) 6 1.4 37 8.9 51 11.1 5 5.7 99 7.1
Other antibacterials (J01X) 11 2.5 19 4.6 16 3.5 4 4.5 50 3.6
Anti-inﬂammatory agents and anti-infectives in combination (S01C) 2 0.5 8 1.9 19 4.1 2 2.3 31 2.2
Antibiotics for topical use (D06A) 8 1.8 9 2.2 7 1.5 3 3.4 27 1.9
Tetracyclines (J01A) 3 0.7 11 2.6 2 0.4 2 2.3 18 1.3
Sulfonamides and trimethoprim (J01E) 5 1.1 – – 6 1.3 – – 11 0.8
Anti-acne preparations for topical use (D10A) 1 0.2 2 0.5 1 0.2 1 1.1 5 0.4
Intestinal antiinfectives (A07A) 2 0.5 2 0.5 – – – – 4 0.3
Aminoglycoside antibacterials (J01G) – – – – 3 0.7 – – 3 0.2
Chemotherapeutics for topical use (D06B) 2 0.5 – – – – – – 2 0.1
Amphenicols (J01B) – – 1 0.2 1 0.2 – – 2 0.1
Corticosteroids, combinations with antibiotics (D07C) – – 1 0.2 – – – – 1 0.1
Total 438 100.0 416 100.0 461 100.0 88 100.0 1403 100.0
Table 5 Distribution of the most commonly prescribed ten antibiotics by healthcare facilities.
Antibiotic (ATC 5 Code) PHCF (n= 438) PH (n= 416) PTE-H (n= 461) UH (n= 88) Total (n= 1403)
n = Total number of antibiotics n % n % n % n % n %
Amoxicillin + clavulanic acid (J01CR02) 115 26.3 69 16.6 46 10.0 24 27.3 254 18.1
Cefuroxime (J01DC02) 43 9.8 45 10.8 38 8.2 7 8.0 133 9.5
Ciproﬂoxacin (J01MA02) – – 29 7.0 26 5.6 6 6.8 66 4.7
Moxiﬂoxacin (J01MA14) 11 2.5 21 5.0 28 6.1 6 6.8 66 4.7
Levoﬂoxacin (J01MA12) 11 2.5 20 4.8 27 5.9 6 6.8 64 4.6
Clarithromycin (J01FA09) 24 5.5 14 3.4 17 3.7 6 6.8 61 4.3
Cefaclor (J01DC04) 22 5.0 12 2.9 17 3.7 – – 52 3.7
Sultamicillin (J01CR04) 12 2.7 – – 26 5.6 2 2.3 51 3.6
Cefpodoxime (J01DD13) 15 3.4 13 3.1 16 3.5 6 6.8 50 3.6
Amoxicillin (J01CA04) 21 4.8 – – – – – – 36 2.6
Cefprozil (J01DC10) 14 3.2 – – – – – – – –
Cefditoren (J01DD16) – – 12 2.9 – – – – – –
Gemiﬂoxacin (J01MA15) – – 12 2.9 – – – – – –
Ceftriaxone (J01DD04) – – – – 18 3.9 – – – –
Nitrofurantoin (J01XE01) – – – – – – 3 3.4 – –
Benzathine benzylpenicillin (J01CE08) – – – – – – 3 3.4 – –
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most common four A. infections, it was found to be
6.54 ± 2.26 days (min: 1, max: 14 days) for A. pharyngitis;
6.50 ± 1.95 days (min: 2, max: 14 days) for A. bronchitis;
6.89 ± 2.37 days (min: 1, max: 14 days) for A. sinusitis and
7.26 ± 2.45 days (min: 1, max: 12 days) for A. tonsillitis. No
statistically signiﬁcant differences were found in the compari-
sons of the durations of antibiotic therapy for these indications
(p> 0.05).
All prescriptions written out for A. infections were also
examined in terms of generic-original antibiotic prescribing.
A total of 359 antibiotics were prescribed for A. infections
and 61.0% of them were generics. When the generic-original
antibiotic prescribing was analyzed by health care facilities, ex-
cept for PHs (48.8%), the percentage of generic antibiotic pre-
scribing was higher in all and PHCFs had the highest (66.5%).
In the comparisons of generic-original antibiotic prescribingby health care facilities, statistically signiﬁcant differences were
found (p< 0.05). These were due to a higher ratio of generic
antibiotic prescribing in PHCFs and a higher ratio of original
antibiotic prescribing in PHs than others. Generic antibiotics
constituted 57.2% of the cost of all antibiotics that were pre-
scribed for A. infections. A comparison of the costs of generic
antibiotic prescribing and original antibiotic prescribing by
health care facilities did not give out any statistically signiﬁ-
cant difference (p> 0.05), (Table 8).
For each of the most common four A. infections, generic-
original antibiotic prescribing was examined. Accordingly,
the percentage of generic antibiotic prescribing was found to
be higher for all indications with the highest percentage for
A. pharyngitis (65.7%) and the lowest percentage for A. sinus-
itis (51.7%). There were no statistically signiﬁcant differences
in the comparisons of generic-original for most common four
A. infections (p> 0.05). The costs of generic and original
Table 6 Distribution of the ATC 4 classiﬁcation of antibiotics by most frequently written for four acute (A.) infections.
ATC classiﬁcation A. pharyngitis A. bronchitis A. sinusitis A. tonsillitis
n % n % n % n %
Beta-lactam antibacterials, penicillins (J01C) 50 46.3 17 17.9 20 34.5 40 66.7
Other beta-lactam antibacterials (J01D) 37 34.3 32 33.7 21 36.2 16 26.7
Macrolides, lincosamides and streptogramins (J01F) 15 13.9 19 20.0 7 12.1 3 5.0
Quinolone antibacterials (J01M) 5 4.6 26 27.4 10 17.2 1 1.7
Other antibacterials (J01X) – – 1 1.1 – – – –
Amphenicols (J01B) 1 0.9 – – – – – –
Total 108 100.0 95 100.0 58 100.0 60 100.0
Table 7 Distribution of the most commonly prescribed ten antibiotics in each four acute (A.) infections.
Antibiotic (ATC 5 Code)
(n=Total number of antibiotics)
A. pharyngitis
(n= 108)
A. bronchitis
(n= 95)
A. sinusitis
(n= 58)
A. tonsillitis
(n= 60)
n % n % n % n %
Amoxicillin + clavulanic acid (J01CR02) 32 29.6 11 11.6 16 27.6 28 46.7
Cefuroxime (J01DC02) 10 9.3 15 15.8 4 6.9 6 10.0
Cefaclor (J01DC04) 7 6.5 – – 4 6.9 2 3.3
Amoxicillin (J01CA04) 6 5.6 – – – – 2 3.3
Azithromycin (J01FA10) 6 5.6 3 3.2 – – – –
Sultamicillin (J01CR04) 5 4.6 4 4.2 2 3.4 – –
Cefpodoxime (J01DD13) 5 4.6 4 4.2 3 5.2 – –
Clarithromycin (J01FA09) 5 4.6 10 10.5 3 5.2 – –
Cefditoren (J01DD16) 4 3.7 – – – – – –
Cefalexin (J01DB01) 3 2.8 – – – – 2 3.3
Gemiﬂoxacin (J01MA15) – – 9 9.5 7 12.1 – –
Moxiﬂoxacin (J01MA14) – – 7 7.4 – – – –
Levoﬂoxacin (J01MA12) – – 7 7.4 – – – –
Cefazolin (J01DB04) – – 5 5.3 – – – –
Ceﬁxime (J01DD08) – – – – 4 6.9 2 3.3
Cefprozil (J01DC10) – – – – 3 5.2 3 5.0
Miocamycin (J01FA11) – – – – 3 5.2 – –
Combinations (J01CE30) – – – – – – 4 6.7
Benzathine benzylpenicillin (J01CE08) – – – – – – 3 5.0
Benzathine phenoxymethylpenicillin
(J01CE10)
– – – – – – 2 3.3
286 S. Mollahaliloglu et al.antibiotics prescribed for the most common four A. infections
were examined. Accordingly, except for A. sinusitis (39.8%), in
all infections, a large part of the total antibiotic cost belonged
to generic antibiotics with the highest ratio for A. pharyngitis
(64.3%). In the comparisons of the costs of generic antibiotic
prescribing and original antibiotic prescribing by indications,
statistically signiﬁcant differences were found. Pertaining to
the cost of the generic antibiotics, A. bronchitis was found
to be different from others (p< 0.05). Pertaining to the cost
of the original antibiotics, on the other side, a statistically sig-
niﬁcant difference was found between bronchitis and pharyngi-
tis, tonsillitis; between pharyngitis and sinusitis; and between
sinusitis and tonsillitis (p< 0.05), (Table 8).
4. Discussion
Evaluation of the prescriptions contributes to conduct effective
strategies for the elimination of the IUA related problems.
This is the ﬁrst study which made an in-depth analysis of theantibiotic utilization by various health care facilities in 10
provinces of Turkey. Besides, the fact that the number of pre-
scriptions per physician was found to be 2.3 serves as an
important indicator of the performance of many physicians
(535 physicians). This study also well reﬂects the antibiotic pre-
scribing attitudes of almost all groups of physicians given the
fact that one-third of the prescriptions was from primary
health care while the second one-third from the internal med-
icine departments and the last one-third from the surgical med-
icine departments.
In this study, NDPP (3.2 drugs) was found to be close to
the value (3.1 drugs) reported in the study which was carried
out with the antibiotic prescriptions with a single diagnosis
(Mollahalilog˘lu et al., 2012).This may be related to the physi-
cians’ tendency to polypharmacy and also multi-diagnosed
prescriptions written for some patients. For instance, a com-
mon trend to prescribe also analgesics, respiratory system
medicines, etc. – in addition to antibiotics – for infections,
can be the other underlying reason, as well. This is also
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Assessment of antibiotic prescribing at different hospitals and primary health care facilities 287supported by the fact that approximately half of the prescrip-
tions (49.1%) included analgesics.
The prescriptions were mostly prescribed for respiratory
tract infections (Table 1). Similarly, another study conducted
in Turkey and two others conducted in Sweden and India also
reported the same ﬁndings that antibiotics were mostly pre-
scribed for respiratory tract infections (Aydın et al., 2005;
Lundborg et al., 2002; Pathak et al., 2011).
NDPP is one of the drug utilization indicators (WHO,
2002). NDPP was found to be 3.23 and it was highest in
PHCFs (3.34), (p< 0.05), (Table 2). This may be related to
the tendency toward prescribing other medicines in PHCFs in-
stead of prescribing a number of antibiotics. When the details
of antibiotic prescribing patterns are evaluated, this ﬁnding
also becomes more clear. One-third of all medicines were anti-
biotics (34.8%). NAPP was 1.12 for all health care facilities,
being highest (1.21) in PTE-Hs (p< 0.05); and lowest (1.04)
in PHCFs (Table 2). In a study which was conducted in a
training hospital in Turkey, NAPP was 1.05 and 3.7% of the
antibiotics were the injectable (Avci et al., 2006). This value,
which was reported in a training hospital, is lower than that
found in UHs (1.19) in this study. On the other hand, consid-
ering 7.3% of the antibiotics were the injectable forms, it can
be deduced that the number of parenteral antibiotics was also
higher. The ﬁndings, which ﬁgured out the fact that 10.6% of
all prescriptions gave out injectable antibiotics and the inject-
able antibiotics constituted three-fourth of these medicines,
also support the view that physicians, in general, are inclined
to prescribe parenteral antibiotics.
The cost of the prescribed medicines is also an important
drug utilization indicator which is signiﬁcant and therefore
used in making an assessment of the RUD performance of
the physicians (Holloway and van Dijk, 2011; WHO, 2002;
De Vries et al., 1994). The study indicated that CPP was
33.32 $ with the highest-cost prescriptions written out in PHs
(p< 0.05) and the lowest-cost prescriptions written out in
PHCFs (Table 2). As for the cost of the prescribed antibiotics,
it constituted half of the cost of all prescriptions (50.2%).
ACPP was 16.73 $, with the highest-cost prescriptions written
out in PHs and PTE-Hs (17.87 $ and 17.71 $, respectively),
(p< 0.05) and with the lowest-cost antibiotics written out in
PHCFs. While NDPP was found highest in PHCFs; NAPP,
CPP and ACPP were lowest in PHCFs (Table 2). Perhaps, it
is because PHCFs rather prefer generics that are less expensive
(Table 8). In addition, as stated above, PHCFs are also in-
clined to prescribe other drugs (usually the drugs that are less
costly than antibiotics). Physicians practicing in PHCFs, for
instance, are more in favor of prescribing additional drugs
such as respiratory system medicines, analgesics, etc. Another
study that reported the use of medicines for respiratory tract
infections in children in Turkey, similarly pointed out that
the respiratory system medicines were the second most com-
monly prescribed medicines following antibiotics (Akici
et al., 2004). Apart from these, PHCFs also provide patients
with treatment of other diseases, which can be associated with
the lower antibiotic prescribing rates in PHCFs. In fact, it was
found out that the prescribing rates for gastrointestinal system
and cardiovascular system medicines which were often subject
of the prescription repeat, were higher in PHCFs than hospi-
tals (Table 3).
The most common diagnosis on the prescriptions was the
respiratory system infections and most of them were the upper
288 S. Mollahaliloglu et al.respiratory tract infections. While assessing the prescriptions,
it was assumed that the diagnoses were correct. On the other
hand, the unavailability to take an additional initiative aiming
to verify the accuracy of the diagnosis and to check if the anti-
biogram tests were given to patients before prescribing antibi-
otics can be considered as limitations of this study. The study
was conducted in November–December, when infectious dis-
eases were common, and did not comprise the remaining ten
months of a year’s time can be considered another limitation.
Penicillins, ‘‘other beta-lactams’’ and quinolones were the
most commonly prescribed antibiotics on prescriptions. In
PHCFs and UHs, penicillins were the most commonly pre-
scribed antibiotics while it was ‘‘other beta-lactams’’ in PHs
and PTE-Hs (Table 4). According to the Intercontinental Med-
ical Statistics (IMS) Health Turkey data, penicillins were the
most commonly prescribed antibiotics in 2001–2006. In this
period, the use of antibiotics had a steady increase particularly
in cephalosporins, quinolones, macrolides and lincosamides
(Karabay and Hosoglu, 2008). Given the higher prescribing
rates of these groups of antibiotics as pointed out by this study,
the afore-mentioned trend of increase is still continuing. In the
literature, there is a wide range of groups of antibiotics that are
commonly used; some groups of antibiotics, particularly peni-
cillins are much more prescribed. A study which analyzed dif-
ferent literatures published between 2000 and 2005 years,
reported that penicillins and macrolides were commonly used
antibiotics for pediatric patients (Rossignoli et al., 2007). A
study, which was carried out with GPs in Denmark and Spain,
ﬁgured out that most GPs in Denmark prescribed narrow-spec-
trum penicillins, followed by macrolides and wide-spectrum
antibiotics while most GPs in Spain prescribed wide-spectrum
penicillins, amoxicillin and beta-lactamase inhibitor combina-
tions for respiratory tract infections. However, the ‘‘quinolone
antibacterials’’, which occupied the third rank in our study,
were not commonly prescribed in Denmark and Spain (Bjer-
rum et al., 2004). A point prevalence study, which was carried
out on inpatients in pediatric hospitals in Turkey, revealed that
cephalosporins and penicillins were the most commonly used
antibiotics while another study carried out in PHCFs pointed
out to beta-lactamase inhibitor combinations and macrolides
being the most commonly used antibiotics (Ceyhan et al.,
2010; Akici et al., 2004). Another study, which was carried
out in the secondary health care level in Kyrgyzstan, reported
that beta-lactam antibacterials-penicillins, aminoglycosides
and cephalosporins were the most commonly prescribed antibi-
otics (Baktygul et al., 2011).
In Mexico, a study analyzing the use of antibiotics for the
upper respiratory tract infections in under 16-aged patients
in private health care indicated that penicillins, cephalosporins
and macrolides were the most commonly used antibiotics (Pel-
a´ez-Ballestas et al., 2003). A study conducted in a training hos-
pital in Turkey found out that co-amoxiclav, quinolones and
cephalosporins were the most commonly prescribed antibiotics
(Avci et al., 2006). In India, a study analyzing the pediatric pa-
tients in the tertiary care level reported cephalosporins as the
most commonly prescribed antibiotics (Sharma et al., 2009).
Another study conducted in the tertiary care level in Nepal re-
ported macrolides, ﬂuoroquinolones and beta-lactams as the
most commonly prescribed antibiotics (Kumar et al., 2010).
As a result, like a number of other national and international
studies in the literature this study also points out that the phy-
sicians rather prefer wide-spectrum antibiotics.Amoxicillin + clavulanic acid and cefuroxime were re-
ported to be the most commonly prescribed antibiotics in all
health care facilities (Table 5). This is another ﬁnding that im-
plies that physicians rather prefer wide-spectrum antibiotics. A
study, which was conducted in PHCFs in Croatia, reported
amoxicillin, co-amoxiclav and co-trimoxazole as the most
commonly prescribed antibiotics (Vojvodic´, 2010). A study,
which was conducted in PHCFs in Denmark and Italy, re-
ported that in Denmark, phenoxymethylpenicillin and amoxi-
cillin; in Italy, amoxicillin and amoxicillin + enzyme inhibitor
combination were the most commonly prescribed antibiotics
(Vaccheri et al., 2002). A study with family physicians from
Poland reported that amoxicillin, amoxicillin + clavulanic
acid and cefuroxime were the most commonly prescribed anti-
biotics for respiratory tract infections (Chlabicz et al., 2004). A
study conducted in PHCFs in Western China indicated that
amoxicillin, benzylpenicillin and norﬂoxacin were the most
commonly prescribed antibiotics (Dong et al., 2008). A com-
prehensive survey on the use of antibiotics in 15 European
countries between 1997 and 2002 concluded that the share of
co-amoxiclav use in the total use of penicillins increased over
years (Vander Stichele et al., 2006). The study from Kyrgyz-
stan, reported that penicillin G, gentamicin and metronidazole
were the most commonly used antibiotics (Baktygul et al.,
2011). The study from Mexico, indicated that amoxicil-
lin + clavulanic acid was the most commonly used antibiotic
(Pela´ez-Ballestas et al., 2003). Another study conducted in
the tertiary care level in Nepal reported azithromycin, cipro-
ﬂoxacin and amoxicillin as the most commonly prescribed
antibiotics (Kumar et al., 2010). A study, which was conducted
in the tertiary care level in Turkey, pointed out to ciproﬂoxacin
being the most commonly used antibiotic (Yapar et al., 2006).
Accordingly, developed by the ﬁndings of all these studies
available in the literature, it is interesting that amoxicillin,
which is among the most commonly used antibiotic in general,
had a lower prescribing rate in our study and was not even pre-
scribed in health care facilities except for PHCFs (Table 5).
The most common four A. infections were also analyzed in
terms of antibiotic utilization patterns. Accordingly, mostly
prescribed antibiotics were found as penicillins for A. pharyn-
gitis and A. tonsillitis and ‘‘other beta-lactams’’ for A. bron-
chitis and A. sinusitis (Table 6). It could be asserted that the
studies in the literature have great variations in antibiotics that
are preferred speciﬁcally for different indications and, in par-
tial, are similar to our ﬁndings. For instance, a study con-
ducted in PHCFs in Turkey reported that beta-lactam and
beta lactamase inhibitors and oral cephalosporins were the
most commonly prescribed antibiotics for A. pharyngitis and
A. sinusitis (Leblebicioglu et al., 2002). Another study con-
ducted in PHCFs in Italy reported that macrolides, cephalo-
sporins, penicillins + beta lactamase inhibitor combinations
and wide-spectrum penicillins were the most commonly pre-
scribed antibiotics for acute respiratory tract infections
(Mazzaglia et al., 1998). A study with GPs in Denmark and
Spain, ﬁgured out that most GPs in Denmark prescribed pen-
icillin V for most A. tonsillitis cases while most GPs in Spain
prescribed wide-spectrum penicillins and macrolides (Bjerrum
et al., 2004).
Although the placement of the most common antibiotic
groups prescribed for A. sinusitis was different from those pre-
scribed for A. pharyngitis and A. tonsillitis; amoxicil-
lin + clavulanic acid was found to be the most commonly
Assessment of antibiotic prescribing at different hospitals and primary health care facilities 289prescribed group for all three infections. Cefuroxime was
found to be the most commonly prescribed antibiotic for A.
bronchitis (Table 7). A study conducted in the PHCFs in Croa-
tia indicated amoxicillin as the most commonly prescribed
antibiotic for A. pharyngitis and A. tonsillitis while another
study conducted in Italy indicated azithromycin as the most
commonly prescribed antibiotic for both indications
(Vojvodic´, 2010; Mazzaglia et al., 1998). The study from Croa-
tia revealed that co-amoxiclav was the most commonly pre-
scribed antibiotic for A. bronchitis and A. sinusitis while a
Polish study revealed that cefuroxime was the most commonly
prescribed antibiotic for A. bronchitis and it was amoxicil-
lin + clavulanic acid for A. sinusitis (Vojvodic´, 2010; Chlabicz
et al., 2004). Another study, which was conducted with pediat-
ric patients diagnosed with acute respiratory tract infection at
hospitals in Spain, reported amoxicillin + clavulanic acid,
amoxicillin and cefuroxime as the most commonly prescribed
antibiotics (Ochoa et al., 2001). In this study, on the other
hand, amoxicillin occupied the fourth rank for A. pharyngitis
and the sixth rank for A. tonsillitis whereas it was not included
in the ﬁrst 10 antibiotics prescribed for A. sinusitis. A recent
randomized controlled trial, which compared amoxicillin with
placebo in the treatment of A. rhinosinusitis indicated that
amoxicillin provided little clinical beneﬁt (Garbutt et al.,
2012). Cochrane review commented that various groups of
antibiotics created similar effects in the treatment of A. sinus-
itis and neither of them had advantages over the others. In new
generation and wide-spectrum antibiotics, the long term effec-
tiveness is reported to be similar, however, further adverse ef-
fects are reported for the use of amoxicillin + clavulanic acid
than cephalosporins and macrolides (Ahovuo-Saloranta et al.,
2011). A meta-analysis reported that in the treatment of A.
sinusitis the more recent ﬂuoroquinolones did not turn out
to be more advantageous than beta-lactam antibiotics (Kara-
georgopoulos et al., 2008). The NICE Guideline of the United
Kingdom does not recommend prescribing antibiotics for A.
bronchitis except for some speciﬁc conditions (NICE, 2008).
Cochrane review acknowledged that satisfactory evidence,
which clearly supports the effectiveness of using antibiotics
for A. bronchitis, is limited (Smith et al., 2011). Cochrane re-
view recommends using penicillins primarily for the treatment
of A. streptococcal pharyngitis in children and adults (van Dri-
el et al., 2011). In children who have penicillin allergy, cepha-
losporins are suggested for use as an alternative to penicillins
(Regoli et al., 2011). In the light of these ﬁndings, it is apparent
that physicians, like in most other cases, were more likely to
prescribe wide-spectrum antibiotics for the four acute infec-
tions reviewed in this study. This likelihood seems even much
more apparent in this study than other studies in the literature.
When the recent debates on whether antibiotics are required
for treatment of these infections or any differences exist be-
tween the patterns of treatment with different groups of anti-
biotics are also taken into consideration, the ﬁndings in this
study reveal the importance of the physicians’ attention while
prescribing antibiotics. The fact that the highest costs of treat-
ment were caused by the prescription of antibiotics puts fur-
ther emphasis on the importance of rational antibiotic
prescribing, as well.
Patients can have non-compliance with antibiotic treatment
for several reasons. Long-term antibiotic treatment is among
these reasons. For instance, a study conducted in Mexico re-
ported that patients’ non-compliance with antibiotic treatmentwas relevant to the treatment schemes that took more than
7 days (Kardas, 2002, 2006; Kardas et al., 2005; Reyes et al.,
1997). In this study, the average duration of antibiotic therapy
was found to be about 7 days for A. infections. A French
study, which made an assessment of antibiotic prescribing, re-
ported an average of 8 days for an antibiotic treatment scheme
(Guillemot et al., 1998). It was found out that average duration
of antibiotic therapy was more than 7 days for A. tonsillitis,
and it took approximately 7 days for A. pharyngitis, A. bron-
chitis and A. sinusitis. A survey conducted in PHCFs in Po-
land found out that physicians usually prescribed antibiotic
treatment for 7.2 days for A. tonsillitis and for 8 days for
sinusitis (Windak et al., 1996). A randomized controlled study,
which was conducted on the patients diagnosed with A. rhi-
nosinusitis and treated with amoxicillin, reported lower clinical
beneﬁts for 10-day amoxicillin treatment schedules in most of
the patients (Garbutt et al., 2012).
Most of the antibiotics prescribed for A. infections were
generics (61.0%) and the generic antibiotic prescribing rates
were higher than original antibiotic prescribing in all health
care facilities except for PHs (p< 0.05), (Table 8). On the
other hand, CPP was found to be highest in PHs (p< 0.05),
(Table 2). Perhaps, it is because PHs had higher original anti-
biotic prescribing rates. The cost of generic antibiotics consti-
tuted 57.2% of total cost of the antibiotics that were prescribed
for A. infections (Table 8). For all of four A. infections, the
generic antibiotic prescribing rates were higher than the origi-
nal antibiotic prescribing rates (Table 8). The use of generic
drugs is becoming more popular in the world and it is com-
monly used as an option to reduce the higher costs of treat-
ments with originals (Weekes and Ramzan, 2010; Garcı´a
Rada, 2011; Godman et al., 2010; Tsiantou et al., 2009; Decol-
logny et al., 2011). This study also indicates that the physicians
in Turkey, in general, are more inclined to prescribe generic
antibiotics than originals.
5. Conclusions
This study made a detailed assessment of the prescriptions
containing antibiotics prescribed in various health care facili-
ties in different provinces across Turkey and gave out some
interesting ﬁndings about the antibiotic utilization. Although
a higher number of medicines were prescribed in PHCFs than
other health care facilities, either CPP or ACPP was found to
be lowest. Physicians’ tendency of prescribing generic medi-
cines in PHCFs can also serve as an underlying reason for this,
in partial. Physicians usually prescribed antibiotics for about
one week’s time and all health care facilities rather preferred
wide-spectrum antibiotics and beta-lactamase combinations,
in particular. It is considered that this study, in the context
of health care facilities and indications, will guide decision-
makers to scale-up the rational use of antibiotics and reim-
bursement systems to provide sustainable services in the
country.
Authors’ contributions
This study was carried out collaboratively by all authors. Mol-
lahaliloglu conducted and managed the research report which
is the basis of this article with Akici, Alkan and Ozgulcu. Akici
and Alkan analyzed the data. Donertas contributed to the data
290 S. Mollahaliloglu et al.analysis and preparation of the article. Akici and Mollahalilo-
glu structured the article. Donertas and Ozgulcu helped to
interpret the study results and review the drafts and the ﬁnal
version of the article. Mollahaliloglu and Akici led the prepa-
ration of the ﬁnal manuscript. All authors read and approved
the article.Acknowledgements
We extend our most sincere thanks to Prof. Dr. Recep AK-
DAG, the MoH of Turkey and to Prof. Dr. Nihat TOSUN,
the Undersecretary of the MoH of Turkey for their invaluable
contributions in developing and publishing the survey report
which this article is based on. We also extend our special thanks
to Dr. Hakki GURSOZ, Dr. Hasan Go¨khun ONCUL, Dr.
Derya ATESOGLU and to Mr. Fatih KARAKAS and to
Mrs. Duygu CEYHAN, Mrs. A. Arzu C¸AKIR, Mrs. Ulger
AYDOGAN together with the involved managers and person-
nel of the Provincial Health Directorate, for their intense efforts
in data collection and assessment. The survey, which this article
is based on, was ﬁnancially supported by a Joint Project imple-
mented by the MoH of Turkey and the World Bank.References
Ahovuo-Saloranta, A., Rautakorpi, U.M., Borisenko, O.V., Liira, H.,
Williams Jr., J.W., Ma¨kela¨, M., 2011. Antibiotics for acute
maxillary sinusitis (Review). Cochrane Libr. (3).
Akdag˘, R. (Ed.), 2011. Republic of Turkey Ministry of Health, Turkey
Health Transformation Program Evaluation Report (2003–2010).
MoH Publication No: 839. ISBN: 978-975-590-377-4.
Akici, A., Kalac¸a, S., Ug˘urlu, M.U., Oktay, S., 2004. Prescribing
habits of general practitioners in the treatment of childhood
respiratory-tract infections. Eur. J. Clin. Pharmacol. 60, 211–216.
Avci, I.Y., Kilic, S., Acikel, C.H., Ucar, M., Hasde, M., Eyigun, C.P.,
Pahsa, A., Cetiner, S., 2006. Outpatient prescription of oral
antibiotics in a training hospital in Turkey: trends in the last
decade. J. Infect. 52, 9–14.
Aydın, S., Yarıs, F., O¨zc¸akır, A., Ag˘alar, C., 2005. Most common
infections and antibiotic prescribing habits of residents: experience
of three university hospitals. Turk J. Med. Sci. 35, 169–173.
Baktygul, K., Marat, B., Ashirali, Z., Harun-Or-rashid, M., Sakam-
oto, J., 2011. An assessment of antibiotics prescribed at the
secondary health-care level in the Kyrgyz Republic. Nagoya J.
Med. Sci. 73, 157–168.
Bjerrum, L., Boada, A., Cots, J.M., Llor, C., Fore´s Garcia, D., Gahrn-
Hansen, B., Munck, A., 2004. Respiratory tract infections in
general practice. Considerable differences in prescribing habits
between general practitioners in Denmark and Spain. Eur. J. Clin.
Pharmacol. 60, 23–28.
Ceyhan, M., Yildirim, I., Ecevit, C., Aydogan, A., Ornek, A., Salman,
N., Somer, A., Hatipog˘lu, N., Camcioglu, Y., Alhan, E., Celik, U.,
Hacimustafaoglu, M., Celebi, S., Inan, D., Kurt, N., Oner, A.F.,
Gulumser, O., Gunes, A., Coskun, Y., 2010. Inappropriate
antimicrobial use in Turkish pediatric hospitals: a multicenter
point prevalence survey. Int. J. Infect. Dis. 14, 55–61.
Chlabicz, S., Magorzata-Otarzewska, A., Pytel-Krolczuk, B., 2004.
Respiratory tract infections: diagnosis and use of antibiotics by
family physicians in north-eastern Poland. Int. J. Antimicrob.
Agents 23, 446–450.
Colgan, R., Powers, J.H., 2001. Appropriate antimicrobial prescribing:
approaches that limit antibiotic resistance. Am. Fam. Physician 64,
999–1004.De Vries, T.P.G.M., Henning, R.H., Hogerzeil, H.V., Fresle, D.A.,
1994. Guide to Good Prescribing. WHO/Action Programme on
Essential Drugs, Geneva.
Decollogny, A., Eggli, Y., Halfon, P., Lufkin, T.M., 2011. Determi-
nants of generic drug substitution in Switzerland. BMC Health
Serv. Res. 11, 17.
Dong, L., Yan, H., Wang, D., 2008. Antibiotic prescribing patterns in
village health clinics across 10 provinces of Western China. J.
Antimicrob. Chemother. 62, 410–415.
European Parliament Directorate General for Internal Policies of the
Union, 2006. Antibiotic Resistance, Report. IP/A/STOA/ST/2006-
4.
Garbutt, J.M., Banister, C., Spitznagel, E., Piccirillo, J.F., 2012.
Amoxicillin for acute rhinosinusitis: a randomized controlled trial.
JAMA 307, 685–692.
Garcı´a Rada, A., 2011. Mandatory generic prescribing is expected to
save Spain euro 2bn a year. BMJ 343, d4803.
Godman, B., Shrank, W., Andersen, M., Berg, C., Bishop, I.,
Burkhardt, T., Garuoliene, K., Herholz, H., Joppi, R., Kalaba,
M., Laius, O., McGinn, D., Samaluk, V., Sermet, C., Schwabe, U.,
Teixeira, I., Tilson, L., Tulunay, F.C., Vlahovic´-Palcˇevski, V.,
Wendykowska, K., Wettermark, B., Zara, C., Gustafsson, L.L.,
2010. Comparing policies to enhance prescribing efﬁciency in
Europe through increasing generic utilization: changes seen and
global implications. Expert Rev. Pharmacoecon. Outcomes Res.
10, 707–722.
Goossens, H., Guillemot, D., Ferech, M., Schlemmer, B., Costers, M.,
van Breda, M., Baker, L.J., Cars, O., Davey, P.G., 2006. National
campaigns to improve antibiotic use. Eur. J. Clin. Pharmacol. 62,
373–379.
Gould, I.M., van der Meer, J.W.M. (Eds.), 2005. Antibiotic Policies
Fighting Resistance. Springer Science+Business Media, Inc.,
United States of America.
Guillemot, D., Carbon, C., Vauzelle-Kervroe¨dan, F., Balkau, B.,
Maison, P., Bouvenot, G., Eschwe`ge, E., 1998. Inappropriateness
and variability of antibiotic prescription among French ofﬁce-
based physicians. J. Clin. Epidemiol. 51, 61–68.
Holloway, K., van Dijk, L., 2011. The World Medicines Situation
2011-Rational use of medicines. WHO, Geneva.
Karabay, O., Hosoglu, S., 2008. Increased antimicrobial consumption
following reimbursement reform in Turkey. J. Antimicrob. Che-
mother. 61, 1169–1171.
Karageorgopoulos, D.E., Giannopoulou, K.P., Grammatikos, A.P.,
Dimopoulos, G., Falagas, M.E., 2008. Fluoroquinolones compared
with beta-lactam antibiotics for the treatment of acute bacterial
sinusitis: a meta-analysis of randomized controlled trials. CMAJ
178, 845–854.
Kardas, P., 2002. Patient compliance with antibiotic treatment for
respiratory tract infections. J. Antimicrob. Chemother. 49, 897–
903.
Kardas, P., 2006. Non-compliance in current antibiotic practice.
Infect. Dis. Clin. Prac. 14, 11–14.
Kardas, P., Devine, S., Golembesky, A., Roberts, C., 2005. A
systematic review and meta-analysis of misuse of antibiotic
therapies in the community. Int. J. Antimicrob. Agents 26, 106–
113.
Kotwani, A., Wattal, C., Katewa, S., Joshi, P.C., Holloway, K., 2010.
Factors inﬂuencing primary care physicians to prescribe antibiotics
in Delhi, India. Fam. Pract. 27, 684–690.
Kumar, J., Shaik, M.M., Kathi, M.C., Deka, A., Gambhir, S.S., 2010.
Prescribing indicators and pattern of use of antibiotics among
medical outpatients in a teaching hospital of Central Nepal. Nepal
Med. Coll. J. 6, 7–13.
Leblebicioglu, H., Canbaz, S., Peksen, Y., Gunaydin, M., 2002.
Physicians’ antibiotic prescribing habits for upper respiratory tract
infections in Turkey. J. Chemother. 14, 181–184.
Llor, C., Cots, J.M., Gaspar, M.J., Alay, M., Rams, N., 2009.
Antibiotic prescribing over the last 16 years: fewer antibiotics but
Assessment of antibiotic prescribing at different hospitals and primary health care facilities 291the spectrum is broadening. Eur. J. Clin. Microbiol. Infect. Dis. 28,
893–897.
Lundborg, C.S., Olsson, E., Mo¨lstad, S; Swedish Study Group on
Antibiotic Use, 2002. Antibiotic prescribing in outpatients: a 1-
week diagnosis-prescribing study in 5 counties in Sweden. Scand. J.
Infect. Dis. 34, 442–448.
Mazzaglia, G., Greco, S., Lando, C., Cucinotta, G., Caputi, A.P.,
1998. Adult acute upper respiratory tract infections in Sicily:
pattern of antibiotic drug prescription in primary care. J. Antimic-
rob. Chemother. 41, 259–266.
Mollahalilog˘lu, S., Alkan, A., Do¨nertas, B., O¨zgu¨lcu¨, S., Akıcı, A.,
2012. Assessment of the antibiotics in out-patient prescriptions
with a diagnosis of a single infection. Marmara Pharm. J. 16, 206–
212.
Mo¨lstad, S., Cars, O., 1999. Major change in the use of antibiotics
following a national programme: Swedish Strategic Programme for
the Rational Use of Antimicrobial Agents and Surveillance of
Resistance (STRAMA). Scand. J. Infect. Dis. 31, 191–195.
Natsch, S., 2005. Audits of antibiotic prescribing. Med. Mal. Infect.
35, 125–126.
National Institute for Health and Clinical Excellence (NICE), 2008.
Respiratory tract infections – antibiotic prescribing: prescribing of
antibiotics for self-limiting respiratory tract infections in adults and
children in primary care.
Niederman, M.S., 2005. Principles of appropriate antibiotic use. Int. J.
Antimicrob. Agents 26, 170–175.
Ochoa, C., Eiros, J.M., Inglada, L., Vallano, A., Guerra, L., 2000.
Assessment of antibiotic prescription in acute respiratory infections
in adults. The Spanish Study Group on Antibiotic Treatments. J.
Infect. 41, 73–83.
Ochoa, C., Inglada, L., Eiros, J.M., Solı´s, G., Vallano, A., Guerra L;
Spanish Study Group on Antibiotic Treatments, 2001. Appropri-
ateness of antibiotic prescriptions in community-acquired acute
pediatric respiratory infections in Spanish emergency rooms.
Pediatr. Infect. Dis. J. 20, 751–758.
Ozgenc¸, O., Genc¸, V.E., Ari, A.A., El, S., Sac¸ar, S., Ozunlu, H., Akgul,
A., Demirturk, N., Cetin, C.B., Sungur, M., Coskuner, S.A., Avci,
M., Ergonul, O.; Antibiotic Resistance Study Group of Turkish
Association of Clinical Microbiology and Infectious Diseases,
2011. Evaluation of the therapeutic use of antibiotics in Aegean
Region hospitals of Turkey: a multicentric study. Indian J. Med.
Microbiol. 29, 124–129.
Pathak, A., Mahadik, K., PHaneria, S.P., Sharma, A., Eriksson, B.,
Lundborg, C.S., 2011. Antibiotic prescribing in outpatients:
Hospital and seasonal variations in Ujjain, India. Scand. J. Infect.
Dis. 43, 479–488.
Pela´ez-Ballestas, I., Herna´ndez-Gardun˜o, A., Arredondo-Garcı´a, J.L.,
Viramontes-Madrid, J.L., Aguilar-Chiu, A., 2003. Use of antibi-
otics in upper respiratory infections on patients under 16 years old
in private ambulatory medicine. Salud Publica Mex. 45, 159–164.
Regoli, M., Chiappini, E., Bonsignori, F., Galli, L., de Martino, M.,
2011. Update on the management of acute pharyngitis in children.
Ital. J. Pediatr. 37, 10.
Reyes, H., Guiscafre´, H., Mun˜oz, O., Pe´rez-Cuevas, R., Martinez, H.,
Gutie´rrez, G., 1997. Antibiotic noncompliance and waste in upperrespiratory infections and acute diarrhea. J. Clin. Epidemiol. 50,
1297–1304.
Rossignoli, A., Clavenna, A., Bonati, M., 2007. Antibiotic prescription
and prevalence rate in the outpatient paediatric population:
analysis of surveys published during 2000–2005. Eur. J. Clin.
Pharmacol. 63, 1099–1106.
Shah, R.C., Shah, P., 2008. Antimicrobial stewardship in institutions
and ofﬁce practices. Indian J. Pediatr. 75, 815–820.
Sharma, R., Chopra, V.S., Kour, G., 2009. Use of antibiotics for
respiratory illnesses in rural India. J. Clin. Diagn. Res. 3, 1557–
1561.
Smith, S.M., Fahey, T., Smucny, J., Becker, L.A., 2011. Antibiotics for
acute bronchitis (Review). Cochrane Libr. (11).
Tsiantou, V., Zavras, D., Kousoulakou, H., Geitona, M., Kyriopo-
ulos, J., 2009. Generic medicines: Greek physicians’ perceptions
and prescribing practices. J. Clin. Pharm. Ther. 34, 547–554.
Turkish Statistical Institute (TurkStat), 2011. Address Based Popula-
tion Registration System Results 2010. Ankara, ISBN: 978-975-19-
5010-9.
Vaccheri, A., Bjerrum, L., Resi, D., Bergman, U., Montanaro, N.,
2002. Antibiotic prescribing in general practice: striking differences
between Italy (Ravenna) and Denmark (Funen). J. Antimicrob.
Chemother. 50, 989–997.
van Driel, M.L., De Sutter, A.I.M., Keber, N., Habraken, H.,
Christiaens, T., 2011. Different antibiotic treatments for group A
streptococcal pharyngitis (Review). The Cochrane Library (1).
Vander Stichele, R.H., Elseviers, M.M., Ferech, M., Blot, S., Goos-
sens, H.; European Surveillance of Antibiotic Consumption
(ESAC) Project Group, 2006. Hospital consumption of antibiotics
in 15 European countries: results of the ESAC Retrospective Data
Collection (1997–2002). J. Antimicrob. Chemother. 58, 159–167.
Vojvodic´, Zˇ., 2010. Antimicrobial use and indication-based prescribing
among general practitioners in Eastern Croatia: comparison with
data from the European Surveillance of Antimicrobial Consump-
tion project. Croat. Med. J. 51, 524–533.
Weekes, L., Ramzan, I., 2010. Generic medicines–how conﬁdent
should we be? Pac. Health Dialog. 16, 109–111.
World Health Organization (WHO), 2001. WHO Global Strategy for
Containment of Antimicrobial Resistance. WHO/CDS/CSR/DRS/
2001.2.
World Health Organization (WHO), 2002. Promoting rational use of
medicines: core components. WHO Policy Perspectives on Medi-
cines no5. WHO/EDM/2002.3.
World Health Organization (WHO), 2003. Introduction to Drug
Utilization Research. ISBN: 92 4 156234 X.
Windak, A., Tomasik, T., Jacobs, H.M., de Melker, R.A., 1996. Are
antibiotics over-prescribed in Poland? Management of upper
respiratory tract infections in primary health care region of
Warszawa. Wola. Fam. Pract. 13, 445–449.
Yapar, N., Erdenizmenli, M., Og˘uz, V.A., Kuruu¨zu¨m, Z., Senger, S.S.,
Cakir, N., Yu¨ce, A., 2006. Infectious disease consultations and
antibiotic usage in a Turkish university hospital. Int. J. Infect. Dis.
10, 61–65.
